Rehovot, Israel

Naama El-Hanany Rozen


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naama El-Hanany Rozen: Innovator in Pharmaceutical Compositions

Introduction

Naama El-Hanany Rozen is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of calcium-related disorders. His innovative approach has led to the development of a unique method that enhances the oral bioavailability of bisphosphonates.

Latest Patents

Naama holds 1 patent for his invention titled "Phosphonates, biphosphonates and pharmaceutical compositions containing them." This patent outlines a method for treating patients with calcium-related disorders by utilizing di- or tripeptide derivatives of bisphosphonates. This advancement is crucial for improving the effectiveness of these compounds in clinical settings.

Career Highlights

Naama is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing treatment options for patients suffering from calcium-related disorders.

Collaborations

Naama has collaborated with esteemed colleagues, including Eli Breuer and Gershon Golomb. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Naama El-Hanany Rozen is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative methods for treating calcium-related disorders demonstrate the importance of research and development in improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…